Disruption of the splicing enhancer sequence within exon 27 of the dystrophin gene by a nonsense mutation induces partial skipping of the exon and is responsible for Becker muscular dystrophy
- PMID: 9410897
- PMCID: PMC508415
- DOI: 10.1172/JCI119757
Disruption of the splicing enhancer sequence within exon 27 of the dystrophin gene by a nonsense mutation induces partial skipping of the exon and is responsible for Becker muscular dystrophy
Abstract
The mechanism of exon skipping induced by nonsense mutations has not been well elucidated. We now report results of in vitro splicing studies which disclosed that a particular example of exon skipping is due to disruption of a splicing enhancer sequence located within the exon. A nonsense mutation (E1211X) due to a G to T transversion at the 28th nucleotide of exon 27 (G3839T) was identified in the dystrophin gene of a Japanese Becker muscular dystrophy case. Partial skipping of the exon resulted in the production of truncated dystrophin mRNA, although the consensus sequences for splicing at both ends of exon 27 were unaltered. To determine how E1211X induced exon 27 skipping, the splicing enhancer activity of purine-rich region within exon 27 was examined in an in vitro splicing system using chimeric doublesex gene pre-mRNA. The mutant sequence containing G3839T abolished splicing enhancer activity of the wild-type purine-rich sequence for the upstream intron in this chimeric pre-mRNA. An artificial polypurine oligonucleotide mimicking the purine-rich sequence of exon 27 also showed enhancer activity that was suppressed by the introduction of a T nucleotide. Furthermore, the splicing enhancer activity was more markedly inhibited when a nonsense codon was created by the inserted T residue. This is the first evidence that partial skipping of an exon harboring a nonsense mutation is due to disruption of a splicing enhancer sequence.
Similar articles
-
An exon skipping-associated nonsense mutation in the dystrophin gene uncovers a complex interplay between multiple antagonistic splicing elements.Hum Mol Genet. 2006 Mar 15;15(6):999-1013. doi: 10.1093/hmg/ddl015. Epub 2006 Feb 6. Hum Mol Genet. 2006. PMID: 16461336
-
A case of Becker muscular dystrophy resulting from the skipping of four contiguous exons (71-74) of the dystrophin gene during mRNA maturation.Proc Assoc Am Physicians. 1996 Jul;108(4):308-14. Proc Assoc Am Physicians. 1996. PMID: 8863344
-
Insertion of a 5' truncated L1 element into the 3' end of exon 44 of the dystrophin gene resulted in skipping of the exon during splicing in a case of Duchenne muscular dystrophy.J Clin Invest. 1993 May;91(5):1862-7. doi: 10.1172/JCI116402. J Clin Invest. 1993. PMID: 8387534 Free PMC article.
-
[Molecular genetics and problems found in genetic diagnosis of Duchenne Becker muscular dystrophy].Nihon Rinsho. 1997 Dec;55(12):3120-5. Nihon Rinsho. 1997. PMID: 9436421 Review. Japanese.
-
[Problems found in genetic diagnosis of DMD/BMD].Rinsho Shinkeigaku. 1995 Dec;35(12):1413-5. Rinsho Shinkeigaku. 1995. PMID: 8752414 Review. Japanese.
Cited by
-
Chemical treatment enhances skipping of a mutated exon in the dystrophin gene.Nat Commun. 2011;2:308. doi: 10.1038/ncomms1306. Nat Commun. 2011. PMID: 21556062 Free PMC article.
-
Hematopoietic cell transplantation provides an immune-tolerant platform for myoblast transplantation in dystrophic dogs.Mol Ther. 2008 Jul;16(7):1340-6. doi: 10.1038/mt.2008.102. Epub 2008 May 27. Mol Ther. 2008. PMID: 18500253 Free PMC article.
-
BRCA2 T2722R is a deleterious allele that causes exon skipping.Am J Hum Genet. 2002 Sep;71(3):625-31. doi: 10.1086/342192. Epub 2002 Jul 19. Am J Hum Genet. 2002. PMID: 12145750 Free PMC article.
-
Antisense Oligonucleotide-Mediated Exon-skipping Therapies: Precision Medicine Spreading from Duchenne Muscular Dystrophy.JMA J. 2021 Jul 15;4(3):232-240. doi: 10.31662/jmaj.2021-0019. Epub 2021 Jul 9. JMA J. 2021. PMID: 34414317 Free PMC article. Review.
-
Nonsense-associated alternative splicing of the human thyroglobulin gene.Mol Diagn. 2005;9(3):143-9. doi: 10.1007/BF03260082. Mol Diagn. 2005. PMID: 16271015
References
Publication types
MeSH terms
Substances
Associated data
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical